Log in to save to my catalogue

Should North America's first and only supervised injection facility (InSite) be expanded in British...

Should North America's first and only supervised injection facility (InSite) be expanded in British...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3599963

Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?

About this item

Full title

Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?

Publisher

England: BioMed Central Ltd

Journal title

Harm reduction journal, 2013-02, Vol.10 (1), p.1-1

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

This article reports qualitative findings from a sample of 31 purposively chosen injection drug users (IDUs) from Vancouver, Surrey and Victoria, British Columbia interviewed to examine the context of safe injection site in transforming their lives. Further, the purpose is to determine whether the first and only Supervised injection facility (SIF)...

Alternative Titles

Full title

Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3599963

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3599963

Other Identifiers

ISSN

1477-7517

E-ISSN

1477-7517

DOI

10.1186/1477-7517-10-1

How to access this item